Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytochrome P-450 2D6 gene polymorphism is not associated with neuroleptic malignant syndrome.

Biological psychiatry - 1 Jul 1996

Ueno S, Otani K, Kaneko S, Koshiro K, Kondoh K, Kotani Y, Sano A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 CYP2D6
Share to DNA Mutational Analysis
Share to Genotype
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 8780858
DOI: 10.1016/0006-3223(95)00427-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytochrome P-450 2D6 gene polymorphism is not associated with neuroleptic malignant syndrome.PMID 8780858Read ↗

Neuroleptic malignant syndrome and hydroxylase gene mutations: no association with CYP2D6A or CYP2D6B.Semantic proximity Read ↗

Mutation involving cytochrome P450IID6 in two Japanese patients with neuroleptic malignant syndrome.Semantic proximity Read ↗

A case study: neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation.Semantic proximity Read ↗

Tardive dystonia and genetic polymorphisms of cytochrome P4502D6 and dopamine D2 and D3 receptors: a preliminary finding.Semantic proximity Read ↗

Lack of association between debrisoquine 4-hydroxylase (CYP2D6) gene polymorphisms and schizophrenia.Semantic proximity Read ↗

Lack of association in Japanese patients between neuroleptic malignant syndrome and a debrisoquine 4-hydroxylase genotype with low enzyme activity.Semantic proximity Read ↗

CYP2D6 gene deletion allele in patients with neuroleptic malignant syndrome: preliminary report.Semantic proximity Read ↗

Lack of association between neuroleptic malignant syndrome and polymorphisms in the 5-HT1A and 5-HT2A receptor genes.Semantic proximity Read ↗

CYP2D6 polymorphism is not associated with essential tremor.Semantic proximity Read ↗

Genotype A1/A2 associated with neuroleptic malignant syndrome.Semantic proximity Read ↗

CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy.Semantic proximity Read ↗

CYP2D6 HhaI genotype and the neuroleptic malignant syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.